Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001128732-21-000005
Filing Date
2021-12-09
Accepted
2021-12-09 14:20:43
Documents
1
Period of Report
2021-10-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2031
  Complete submission text file 0001128732-21-000005.txt   3665
Mailing Address 6198 SOUTH MOLINE COURT ENGLEWOOD CO 80111
Business Address
TELSEY ANDREW I (Reporting) CIK: 0001103152 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52898 | Film No.: 211481645

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Issuer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research